Shen, Cheng-Cheng <br/><br/>
AMD3100 treatment attenuates pulmonary angiogenesis by reducing the c-kit (+) cells and its pro-angiogenic activity in CBDL rat lungs.  [electronic resource] 

 -  Biochimica et biophysica acta. Molecular basis of disease  Mar 2018 
 - 676-684 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0925-4439 
<br/><br/><label>Standard No.: </label>10.1016/j.bbadis.2017.12.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzylamines<br/>Cells, Cultured<br/>Common Bile Duct--pathology<br/>Cyclams<br/>Down-Regulation--drug effects<br/>Hepatopulmonary Syndrome--drug therapy<br/>Heterocyclic Compounds--pharmacology<br/>Ligation<br/>Lung--blood supply<br/>Male<br/>Neovascularization, Pathologic--pathology<br/>Proto-Oncogene Proteins c-kit--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Signal Transduction--drug effects